Global COVID 19 Impact On Vaccines & Drugs Market Share
The COVID-19 effect on the market for medications and vaccines in the region is broken down into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Because large pharmaceutical companies in North America have the financial resources to develop vaccines, the area leads the world in terms of market share. However, throughout the projected period of 2020–2026, Asia–Pacific is also anticipated to record the most significant growth rate or CAGR. This is mainly attributable to expanding populations and an increase in instances, which, when combined with early clinical trial approvals, would offer lucrative growth opportunities for the Asia-Pacific vaccine and medication market.